Authors
Latest:
Oncology Overview: Akynzeo for Chemotherapy-Induced Nausea and VomitingCombination netupitant and palonosetron capsules/fosnetupitant and palonosetron for injection (Akynzeo) is indicated to prevent acute and delayed nausea and vomiting associated with highly emetogenic chemotherapy.
Latest:
How Smarter Collaboration Helps Pharmacy Professionals Achieve Their GoalsPharmacy professionals can bring in the right people at the right time to identify needed changes and develop an action plan.
Latest:
Disparities in Chronic Disease Outcomes Require SolutionsFinding ways to eliminate barriers to care helps narrow the gap.
Latest:
Speech Therapy May Effectively Address Long COVID Communication IssuesIn addition to the physical symptoms of long COVID, patients have reported vocal, verbal, and cognitive issues that disrupt their ability to communicate.
Latest:
Sugammadex: Use Criteria Optimization and Outcomes Data EvaluationEstablishing new use criteria led to an 86% reduction in the utilization of sugammadex with no appreciable impact on measured outcomes.
Latest:
Updates in Renal Cell Carcinoma ManagementImmunotherapies will continue to change standards of care for treatment of RCC.
Latest:
The Impact of Prior Authorization on Patients With CancerPrior authorizations have delayed time to treatment for patients and can directly impact clinical outcomes.
Latest:
Implementing USP <800> Guidelines in Pediatric HospitalsProtecting this vulnerable patient population requires specially designed strategies.
Latest:
Optimizing Patient Data in the Time of COVID-19Pharmacists must remain nimble to help patients continue receiving the medications they need, as technology now plays a central role in workflow and medication management.
Latest:
Reimbursement Advancement of Clinical Pharmacy ServicesClinical pharmacy services became eligible for reimbursement by all health insurance in Germany; however, challenges persist in upscaling and sustaining these services.
Latest:
What Is Going On With Male Contraception?Sixty years after the first hormonal birth control pill was marketed to women, men still have limited options with variable efficacy for birth control.
Latest:
Clinical Overview: Treatment of Schizophrenia, Schizoaffective DisordersThe mainstay of treatment for schizophrenia and schizoaffective disorder includes antipsychotics.
Latest:
Genetic Predictors of Progressive Multifocal LeukoencephalopathyThe implementation of genetic testing for patients prescribed medications associated with progressive multifocal leukoencephalopathy is likely to improve safety outcomes.
Latest:
Emerging HER2-Targeted Therapies in NSCLC: Zongertinib and BAY 2927088HER2-mutant NSCLC is associated with poor prognosis. Zongertinib and BAY 2927088 are HER2 tyrosine kinase inhibitors that have activity in NSCLC with manageable toxicity profiles.
Latest:
When to Call, When to Counsel: Fluoroquinolone TendinopathyA collaborative health care approach enhances patient outcomes and supports informed decision-making in antibiotic management.
Latest:
Focus on Multiple Sclerosis: Benefits of Advanced Pharmacist Certification, a Glimpse into the Drug PipelinePharmacists who educate patients with multiple sclerosis and expand their understanding and knowledge of the condition empowers them to take part in a more active role in managing their health.
Latest:
Speaking a Second Language Has Countless Benefits in the Pharmacy SettingBeing able to communicate in a different language can improve treatment adherence and medication efficacy outcomes
Latest:
The Evolving Role of Adjuvant Immunotherapy in Resected Renal Cell Carcinoma: Key Findings and Future DirectionsThe adjuvant therapy has demonstrated varied efficacy for patients.
Latest:
If You Want to Know Where Pharmacists' Roles Are Heading, Follow PatientsLast year in particular, pharmacists played a greater role in patient care with an increased workload as they connected patients, providers, and payers.
Latest:
Eculizumab and Other Therapies for the Treatment of High-Risk Transplant-Associated Thrombotic MicroangiopathyEculizumab (Soliris; Alexion), a C5 inhibitor preventing cleavage into C5a and C5b, is widely considered the first-line therapy for high-risk TA-TMA.
Latest:
Key Takeaways on FMTs in the Treatment of CDIExperts provide practice pearls for educating patients on and using FMTs for the management of CDI.
Latest:
The Role of Site Management Organizations in Clinical Trial ManagementSMOs offer a range of services, including site selection, patient recruitment, data management, regulatory compliance, and quality assurance.
Latest:
Common Patient Questions About Insulin Biosimilars Pertain to ClassificationNuances can lead to frequent areas of confusion.
Latest:
Standardizing Infusion Pumps in Large Health Systems Enhances SafetyAnalyzing consolidation of 8 drug pump libraries into 1 IV infusion library in a 9-hospital system: from standardization to implementation.
Latest:
Chronic Lymphocytic Leukemia: A Review of Noncovalent BTK Inhibitors, Novel Agents, and Toxicity Management of BTK InhibitorsThis article discusses clinical data for noncovalent Bruton tyrosine kinase inhibitors (BTKis), novel strategies in CLL, and the practical management of BTKi toxicities.
Latest:
Novel Drug Combinations in Precision Medicine Are an Emerging Landscape for PharmacistsA single-center experience at a tertiary medical center precision medicine clinic provides insight.
Latest:
Veteran Care Should Be Added to PharmD CurriculumStudies show a need for coordination between the VA health care system and non-VA health care practices to decrease confusion and duplication of services.
Latest:
Optimizing Point-of-Care Testing for Greater Reliability, EfficacyPoint-of-care testing can vary in complexity, but is always performed at or near a patient and at the site where care or treatment is provided.
